|
|
|
| |
Basic InformationMore InformationTestsLatest NewsQuestions and AnswersBlog EntriesDepression, ADHD, Psychotherapy and MedicationAdult AD/HD: Effects on Relationships and Self-EsteemThe Brain, Nutrition and ADHD"I Can't," Living with ADHDExploring the Upside of ADHDDo I Have ADD?Mindfulness and ADHD: A Tip from Dr. Lidia ZylowskaADHD - Breaking the Cycle of ShameADHD, Medication and ExercisePersonality Disorders and Attention Deficit/Hyperactivity DisorderAdolescents with ADHD and the Risk of Internet AddictionMindful Approaches for Adult ADHDChildren, ADHD and Stimulant MedicationThere is No Such Thing as ADDADHD and Brain Stimulation ADHD and Stimulant Medications, A Matter of JudgementLearning While Fidgeting: ADHDIt Is Not All PsychologicalParents of Children with ADHDChildren with ADHD and their FamiliesADHD Psychological Coaching: Learning to Cope without MedicationThe Amazing Story of a Boy Who Would Never Focus on AnythingI Thought I was Dumb: The Story of Ben Kilham, Bear ExpertAn Additional Comment About ADHD, It's Really RealADHD, It's Really RealInvolving Fathers in the Treatment of Children with ADHDAttention Deficit Disorder, A Personal AccountAdult ADHD: The Importance of Learning Social SkillsDo You Have Adult ADHD?Marriage, Family and Adult ADHDSmoking and ADHDDose-Response Curves and Treatment of ADHD, AddictionsNew drug warnings for ADHD stimulantsA New Way to Buffer Amphetamine For ADHD TreatmentTeachers as Brokers for ADHDPlaystation Neurofeedback Hybrid for ADHD TreatmentDaytrana skin patch for ADHD just approvedAdult ADHD: Difficult to Diagnose and Often Misunderstood VideosLinksBook ReviewsSelf-Help Groups |
| | | |
Dopamine Reward Pathway Linked to ADHD Deficits(HealthDay News)
by -- Jeff Muise
Updated: Sep 8th 2009
TUESDAY, Sept. 8 (HealthDay News) -- Rewards-motivation deficits reported in people with attention-deficit/hyperactivity disorder (ADHD) may be associated with a disruption in the mesoaccumbens dopamine reward pathway evidenced by reduced dopamine synaptic markers seen in positron emission tomography (PET) imaging of the brain, according to a study in the Sept. 9 issue of the Journal of the American Medical Association.
Nora D. Volkow, M.D., of the National Institute on Drug Abuse in Bethesda, Md., and colleagues performed PET imaging on 53 subjects with ADHD who were not on medication, along with 44 healthy subjects, to study activity in the brain's mesoaccumbens dopamine reward pathway, which is believed to be involved in rewards-motivation behavior. Specific binding of positron emission tomographic radioligands for dopamine transporters (DAT) were measured using [11C]cocaine and for D2/D3 receptors.
The researchers found lowered specific binding for both ligands in the left-side brain regions involved in the dopamine reward pathway in the subjects with ADHD. The mean for DAT in the nucleus accumbens was 0.63 for the ADHD subjects and 0.71 for controls, and in the midbrain was 0.09 for the ADHD subjects and 0.16 for controls. For the D2/D3 receptors, the median in the accumbens for the ADHD subjects was 2.68 and 2.85 for controls, and in the midbrain was 0.18 for the ADHD subjects and 0.28 for controls.
"In conclusion, these findings show a reduction in dopamine synaptic markers in the dopamine reward pathway midbrain and accumbens region of participants with ADHD that were associated with measures of attention," the authors write.
Several of the study authors reported receiving research support and consulting fees from pharmaceutical companies.
Abstract
Full Text (subscription or payment may be required)
This article: Copyright © 2009 ScoutNews, LLC. All rights reserved. |
| 
|
|
|
|
